Dentsply Sirona
Dentsply Sirona is a global leader in dental products and technologies, offering a comprehensive suite of solutions for professionals worldwide. The company’s substantial commitment to the dental bone graft substitutes market is demonstrated through its specialized Symbios brand, which is recognized for providing a trustworthy portfolio of bone formation solutions essential for positive dental experiences and long-term implant success. Symbios offers a diverse array of regenerative materials, including allograft solutions (mineralized and demineralized particulates, putty), xenograft granules (Symbios Xenograft Granules), and synthetic bone graft material (pure synthetic hydroxylapatite) for bulk and contour maintenance. Furthermore, the portfolio encompasses resorbable and non-resorbable membranes—such as the Symbios Collagen Membrane SR and Symbios OsteoShield Collagen Resorbable Membrane—for Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR). By integrating these high-quality bone graft materials and barrier membranes with precision instruments, Dentsply Sirona provides clinicians with the necessary tools to address complex clinical situations, ensuring sufficient volume of healthy bone for successful dental implant placement and reconstruction.
Latest Market Research Report on Dental Bone Graft Substitute Download PDF Brochure Now
Straumann Group
The Straumann Group is a global pioneer and leader in implant, restorative, and regenerative dentistry. Its strategic involvement in the dental bone graft substitute market is part of its comprehensive full-arch and digital solutions designed to improve clinical outcomes and simplify patient journeys. The company actively develops and promotes a regenerative portfolio that is critical for implant-site management and tooth preservation, with products including highly effective Bone Grafts and Membranes. Straumann leverages its deep understanding of osseointegration and digital workflows to ensure its biomaterials integrate seamlessly with its implant systems. This commitment is evidenced by offerings like the creos syntogain synthetic bone substitute, introduced by its subsidiary Nobel Biocare, which features a multidirectional interconnected porous structure. Straumann’s focus on integrating regenerative solutions, advanced implantology, and digital technology provides practitioners with a holistic approach to address bone deficiencies, thus reinforcing its position as a key global player in the dental bone graft substitutes industry.
Medtronic
Medtronic is one of the world’s largest medical technology companies, playing a vital role in the dental bone graft substitutes market through its focus on advanced biologics. The company provides critical solutions for orthopedic and dental bone regeneration, with a portfolio anchored by its allograft and growth factor technologies. A cornerstone of their offering is Grafton™ Demineralized Bone Matrix (DBM), an allograft tissue product used as a bone graft extender or substitute. Grafton DBM is intended for packing into bony voids or gaps in dental, oral, and cranio-/maxillofacial defects, providing an osteoconductive and osteoinductive scaffold for bone healing. Additionally, Medtronic provides Infuse™ Bone Graft, a growth factor option consisting of a synthetic version of the protein BMP-2, which is highly potent at regulating bone healing and growth. This dual approach, leveraging both allograft tissue and recombinant growth factors, allows Medtronic to address a wide range of bone grafting needs, from minor defects to complex reconstructive procedures, reinforcing its influence across the broader bone graft and substitute sector.
ZimVie
ZimVie Inc. is a company dedicated to transforming the lives of patients through its dental and spine solutions, having been spun off from the medical giant Zimmer Biomet. In the dental bone graft substitutes market, ZimVie offers a comprehensive and multi-material product line tailored for various surgical applications. Their portfolio includes the well-established Puros® Allograft Bone Grafts, which come in multiple forms such as cortical, cancellous, and demineralized bone matrix (DBM) particulates and blocks. They also feature the RegenerOss® brand, which includes allograft putties and the RegenerOss® Resorbable Xenograft. A key focus is on innovation, demonstrated by new product launches like the RegenerOss CC Allograft Particulate and the RegenerOss Bone Graft Plug, which are designed for minimally invasive procedures like socket preservation and periodontal defects. ZimVie’s diverse offering, which also includes IngeniOs® synthetic bone grafts, positions the company as a provider committed to delivering highly specific and effective bone regeneration materials to dental professionals.
Geistlich Pharma
Geistlich Pharma AG is a Swiss-based company that has established itself as a highly specialized leader in regenerative dentistry and orthopedics, with a deep focus on developing and distributing natural biomaterials. The company is recognized globally for holding a major market share and is often cited as a key industry player due to its flagship products, which include gold-standard xenograft and collagen membrane solutions. Geistlich’s products are essential for guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures, and are used widely in applications such as sinus lift, ridge augmentation, and socket preservation to achieve predictable bone and soft tissue healing. Geistlich’s success is built on extensive clinical evidence and a rigorous scientific foundation, which reinforces its reputation among dental professionals as a reliable provider of high-quality, scientifically-backed products, ensuring its continued prominence in the dental bone graft substitutes market.
Johnson & Johnson
Johnson & Johnson (J&J) is a multinational healthcare and medical device powerhouse whose sheer size and market penetration make it a pivotal participant in the dental bone graft substitutes sector. As a global conglomerate, J&J’s influence is often exerted through its subsidiary companies and medical device segment, which offer a broad range of orthobiologics, including bone graft materials and related surgical products. The company’s immense research and development capabilities allow it to drive innovation in biomaterials, focusing on developing new synthetic and biological graft substitutes that meet stringent regulatory standards. While specific J&J dental brands are less frequently highlighted in the competitive landscape compared to its specialized dental counterparts, its continuous presence in top market share reports underscores its role as an influential market shaper. J&J’s commitment to providing advanced, reliable, and high-quality medical products ensures it remains a significant and foundational competitor in the global market for dental bone graft and substitute materials.
BioHorizons Implant Systems Inc.
BioHorizons Implant Systems Inc. is a company that specializes in evidence-based dental implants and tissue regeneration products, making it a critical player in the dental bone graft substitutes market. The company provides a focused portfolio of biomaterials essential for achieving successful implant outcomes and predictable bone healing. BioHorizons’ regenerative line includes a diverse range of materials such as allografts and xenografts. For instance, their offering includes xenografts like MinerOss® X and MinerOss® XP, which are bovine-derived bone graft materials used for various augmentation procedures. They also provide allograft options like the MinerOss® line (in cancellous, cortical, and blend forms) and bone graft putties like MinerOss® Putty and Grafton® DBM, often in partnership with other tissue providers. By concentrating on high-quality, scientifically proven products for bone and soft tissue grafting, BioHorizons directly supports dental professionals in procedures such as sinus lifts and socket preservation, reinforcing its dedicated niche in the dental surgery and regeneration field.
ACE Surgical Supply Co. Inc.
ACE Surgical Supply Co. Inc. functions as a specialized distributor and manufacturer in the dental surgery and implantology fields, offering a comprehensive array of products that firmly place it as a key market player in dental bone graft substitutes. The company’s strength lies in providing a wide selection of grafting materials from various sources to dental surgeons and periodontists. Their bone graft portfolio includes allografts (such as the alloOss line of mineralized, demineralized, and composite products), xenografts (NuOss Cortical Bone Graft Granules), and synthetic options (Synoss Synthetic Bone Particulate). These materials are offered in various forms, including granules, putty, and plugs, to suit different clinical needs, such as socket preservation and ridge augmentation. ACE Surgical also supplies complementary products like barrier membranes (Cytoflex, Collashield) and instruments, positioning itself as a reliable, one-stop source for the complete bone regeneration workflow, ensuring clinicians have access to a breadth of high-quality materials for their surgical practices.
Latest Market Research Report on Dental Bone Graft Substitute Download PDF Brochure Now